Search results for "Prostate cancer"
Discussion of stopping cancer screening may go best when focused on lack of benefit instead of limited life expectancy
Survey respondents' most preferred phrase was “your other health issues should take priority”; the least preferred choice was “the doctor does not give an explanation.”
https://immattersacp.org/weekly/archives/2018/07/03/4.htm
3 Jul 2018
Aiding patients' decisions on PSA screening
Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
https://immattersacp.org/archives/2011/07/prostate.htm
1 Jul 2011
Radical prostatectomy for localized cancer extended life span compared to watchful waiting
The amount of absolute benefit from surgery depended on the baseline risk defined by extracapsular extension and a Gleason score higher than 7, according to long-term follow-up data from a Scandinavian study.
https://immattersacp.org/weekly/archives/2018/12/18/4.htm
18 Dec 2018
‘Smart’ drugs could be bad idea
This issue covers performance-enhancing drugs, prostate cancer options, and transgender health.
https://immattersacp.org/archives/2017/11/smart-drugs-could-be-bad-idea.htm
1 Nov 2017
Propoxyphene withdrawn, bevacizumab loses indication
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/02/fda.htm
1 Feb 2011
Peanut butter recall issued, reminder for topical anesthetics
A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/03/fda.htm
1 Mar 2009
MKSAP Quiz: Exacerbations of heart failure
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018
Recall of generic drugs, acne cream; depression device OK'd
A summary of approvals, recalls and a record number of deaths and serious injuries reported.
https://immattersacp.org/archives/2009/01/recall.htm
1 Jan 2009
Task Force draft recommendation leaves PSA screening choice up to patients
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017
Taking a drink: what patients should know
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013